Verona Pharma plc (NASDAQ:VRNA) Q1 2025 Earnings Call Transcript April 29, 2025
Verona Pharma plc beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.22.
Operator: Welcome to Verona Pharma plc’s First Quarter 2025 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode. I would now like to turn the call over to Victoria Stewart, Senior Director, Investor Relations and Communications. Please go ahead.
Victoria...
